Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, researches, develops, and commercializes products to address medication abuse and misuse. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; Egalet Ltd.; and Egalet Corporation to manufacture and commercialize Oxaydo products worldwide. The company was founded in 1935 and is based in Palatine, Illinois.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2023-01-02 |
2022-09 |
0 |
N/A |
N/A |
N/A |
2022-10-03 |
2022-06 |
0 |
N/A |
N/A |
N/A |
2022-07-05 |
2022-03 |
0 |
N/A |
N/A |
N/A |
2022-03-30 |
2021-12 |
0 |
N/A |
N/A |
N/A |
2021-11-15 |
2021-09 |
0 |
N/A |
N/A |
N/A |
2021-08-16 |
2021-06 |
0 |
-0.01 |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2015-02-26 |
MLV & Co |
Upgrade |
Hold |
Buy |
2014-05-27 |
MLV & Co |
Downgrade |
Buy |
Hold |
2013-08-13 |
MLV & Co |
Upgrade |
|
Buy |
Date |
Name |
Relation |
Quantity |
Description |
2017-01-02 |
ROSS GEORGE K |
Director |
11.57K |
Option Exercise |
2017-02-06 |
SEISER ROBERT A |
Officer |
22.49K |
Option Exercise |
2017-01-02 |
SKELLY WILLIAM G |
Director |
28.35K |
Option Exercise |
2017-01-02 |
THANGARAJ IMMANUEL |
Director |
23.81K |
Option Exercise |
2017-01-02 |
WESSON BRUCE F |
Director |
58.67K |
Option Exercise |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2016-12-30 |
Essex Woodlands Health Ventures |
1.96M |
1.51M |
16.46% |
2016-12-30 |
Deerfield Management |
1.03M |
789.74K |
8.63% |
2016-12-30 |
Vanguard Group, Inc. (The) |
195.94K |
150.88K |
1.65% |
2016-12-30 |
Renaissance Technologies, LLC |
113.22K |
87.18K |
0.95% |
2016-12-30 |
Sabby Management, LLC |
103.44K |
79.65K |
0.87% |
2016-12-30 |
KCG Holdings, Inc. |
44.57K |
34.32K |
0.38% |
Report Date |
Organization |
Position |
Value |
Percentage |
2016-09-29 |
Vanguard Extended Market Index Fund |
89.12K |
142.59K |
0.75% |
2016-09-29 |
Vanguard Total Stock Market Index Fund |
61.76K |
98.81K |
0.52% |
2016-11-29 |
Fidelity Extended Market Index Fund |
18.76K |
17.26K |
0.16% |
2016-11-29 |
iShares Core S&P Total U.S. Stock Market ETF |
9.86K |
9.07K |
0.08% |
2016-07-30 |
Schwab Capital Trust-Total Stock Market Index Fund |
4.18K |
8.11K |
0.04% |
2016-09-29 |
Quantitative Master Series Tr-Extended Market Index Series |
3.20K |
5.13K |
0.03% |
Split |
Date |
1 : 5 |
2015-08-28 |
1 : 5 |
2015-08-27 |
0.1 : 1 |
2007-12-05 |